A marriage between Schering-Plough’s Claritin and Merck’s Singulair allergy drugs doesn’t seem meant to be.
The companies said late Friday that the FDA had rejected an application for a pill that would combine the two drugs. Without explaining the FDA’s reasoning, they said they were “evaluating the agency’s response.”
The idea of a Singulair-Claritin combo had [...] ...
Anytime
